In order to gather both qualitative and quantitative insights, supply-side and demand-side stakeholders were interviewed during the primary research process. CEOs, VPs of Product Development, heads of regulatory affairs, and commercial directors from companies that produce algal proteins, biotechnology companies, and culture technology suppliers were examples of supply-side sources. Food and beverage formulators, nutraceutical product developers, animal feed nutritionists, cosmetic chemists, procurement leads from food manufacturing firms, dietary supplement brands, and sustainability officials from large consumer packaged goods corporations were examples of demand-side suppliers. In addition to gathering information on supply chain dynamics, pricing tactics, and formulation adoption patterns, primary research verified cultivation facility expansion timetables and validated market segmentation.
Primary Respondent Breakdown:
By Designation: C-level Primaries (32%), Director Level (30%), Others (38%)
By Region: North America (38%), Europe (25%), Asia-Pacific (28%), Rest of World (9%)
Production volume analysis and revenue mapping were used to get the global market valuation. The methodology comprised:
Finding more than fifty important manufacturers in North America, Europe, Asia-Pacific, and Latin America
Product mapping between the protein groups of spirulina, chlorella, Dunaliella salina, Haematococcus pluvialis, and other algae
Examination of reported and projected yearly income for portfolios of algal proteins
coverage of producers accounting for 75–80% of the world market in 2024
Extrapolation to obtain segment-specific valuations utilizing top-down (manufacturer revenue validation) and bottom-up (production volume × ASP by nation) methods